These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 17696873)

  • 1. Human wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implications.
    Cellini B; Bertoldi M; Montioli R; Paiardini A; Borri Voltattorni C
    Biochem J; 2007 Nov; 408(1):39-50. PubMed ID: 17696873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human liver peroxisomal alanine:glyoxylate aminotransferase: Different stability under chemical stress of the major allele, the minor allele, and its pathogenic G170R variant.
    Cellini B; Lorenzetto A; Montioli R; Oppici E; Voltattorni CB
    Biochimie; 2010 Dec; 92(12):1801-11. PubMed ID: 20713123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Insight into the Synergism between the Minor Allele of Human Liver Peroxisomal Alanine:Glyoxylate Aminotransferase and the F152I Mutation.
    Cellini B; Montioli R; Paiardini A; Lorenzetto A; Voltattorni CB
    J Biol Chem; 2009 Mar; 284(13):8349-58. PubMed ID: 19155213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of human alanine:glyoxylate aminotransferase in Escherichia coli: renaturation from guanidine-HCl and affinity for pyridoxal phosphate co-factor.
    Coulter-Mackie MB; Lian Q; Wong SG
    Protein Expr Purif; 2005 May; 41(1):18-26. PubMed ID: 15802217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gly161 mutations associated with Primary Hyperoxaluria Type I induce the cytosolic aggregation and the intracellular degradation of the apo-form of alanine:glyoxylate aminotransferase.
    Oppici E; Roncador A; Montioli R; Bianconi S; Cellini B
    Biochim Biophys Acta; 2013 Dec; 1832(12):2277-88. PubMed ID: 24055001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxalate synthesis in mammals: properties and subcellular distribution of serine:pyruvate/alanine:glyoxylate aminotransferase in the liver.
    Ichiyama A; Xue HH; Oda T; Uchida C; Sugiyama T; Maeda-Nakai E; Sato K; Nagai E; Watanabe S; Takayama T
    Mol Urol; 2000; 4(4):333-40. PubMed ID: 11156700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treponema denticola cystalysin exhibits significant alanine racemase activity accompanied by transamination: mechanistic implications.
    Bertoldi M; Cellini B; Paiardini A; Di Salvo M; Borri Voltattorni C
    Biochem J; 2003 Apr; 371(Pt 2):473-83. PubMed ID: 12519070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of the S187F variant of human liver alanine: glyoxylate [corrected] aminotransferase associated with primary hyperoxaluria type I and its functional implications.
    Oppici E; Fodor K; Paiardini A; Williams C; Voltattorni CB; Wilmanns M; Cellini B
    Proteins; 2013 Aug; 81(8):1457-65. PubMed ID: 23589421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misfolding caused by the pathogenic mutation G47R on the minor allele of alanine:glyoxylate aminotransferase and chaperoning activity of pyridoxine.
    Montioli R; Oppici E; Dindo M; Roncador A; Gotte G; Cellini B; Borri Voltattorni C
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1280-9. PubMed ID: 26149463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the E177K mutation in D-amino acid transaminase. Studies on an essential coenzyme anchoring group that contributes to stereochemical fidelity.
    van Ophem PW; Peisach D; Erickson SD; Soda K; Ringe D; Manning JM
    Biochemistry; 1999 Jan; 38(4):1323-31. PubMed ID: 9930994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction, purification and characterization of untagged human liver alanine-glyoxylate aminotransferase expressed in Escherichia coli.
    Cellini B; Montioli R; Bianconi S; López-Alonso JP; Voltattorni CB
    Protein Pept Lett; 2008; 15(2):153-9. PubMed ID: 18289107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional synergism between the most common polymorphism in human alanine:glyoxylate aminotransferase and four of the most common disease-causing mutations.
    Lumb MJ; Danpure CJ
    J Biol Chem; 2000 Nov; 275(46):36415-22. PubMed ID: 10960483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human liver peroxisomal alanine:glyoxylate aminotransferase: characterization of the two allelic forms and their pathogenic variants.
    Cellini B; Montioli R; Voltattorni CB
    Biochim Biophys Acta; 2011 Nov; 1814(11):1577-84. PubMed ID: 21176891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and cellular effects of a novel missense mutation of the AGXT gene associated with Primary Hyperoxaluria Type 1.
    Gatticchi L; Dindo M; Pampalone G; Conter C; Cellini B; Takayama T
    Biochem Biophys Res Commun; 2023 Feb; 645():118-123. PubMed ID: 36682331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of low native state kinetic stability and interaction of partially unfolded states with molecular chaperones in the mitochondrial protein mistargeting associated with primary hyperoxaluria.
    Pey AL; Salido E; Sanchez-Ruiz JM
    Amino Acids; 2011 Nov; 41(5):1233-45. PubMed ID: 21103899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The N-terminal extension is essential for the formation of the active dimeric structure of liver peroxisomal alanine:glyoxylate aminotransferase.
    Montioli R; Fargue S; Lewin J; Zamparelli C; Danpure CJ; Borri Voltattorni C; Cellini B
    Int J Biochem Cell Biol; 2012 Mar; 44(3):536-46. PubMed ID: 22198249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cycloserine enantiomers are reversible inhibitors of human alanine:glyoxylate aminotransferase: implications for Primary Hyperoxaluria type 1.
    Dindo M; Grottelli S; Annunziato G; Giardina G; Pieroni M; Pampalone G; Faccini A; Cutruzzolà F; Laurino P; Costantino G; Cellini B
    Biochem J; 2019 Dec; 476(24):3751-3768. PubMed ID: 31794008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactions of human liver peroxisomal alanine:glyoxylate aminotransferase with beta-chloro-L-alanine and L-cysteine: spectroscopic and kinetic analysis.
    Bertoldi M; Cellini B; Paiardini A; Montioli R; Borri Voltattorni C
    Biochim Biophys Acta; 2008 Sep; 1784(9):1356-62. PubMed ID: 18492492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of interface mutations on the dimerization of alanine glyoxylate aminotransferase and implications in the mistargeting of the pathogenic variants F152I and I244T.
    Dindo M; Montioli R; Busato M; Giorgetti A; Cellini B; Borri Voltattorni C
    Biochimie; 2016 Dec; 131():137-148. PubMed ID: 27720751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with primary hyperoxaluria type I.
    Oppici E; Montioli R; Lorenzetto A; Bianconi S; Borri Voltattorni C; Cellini B
    Mol Genet Metab; 2012 Jan; 105(1):132-40. PubMed ID: 22018727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.